Bausch Health Companies Inc. (BHC)
NYSE: BHC · Real-Time Price · USD
6.46
+0.05 (0.78%)
At close: Jun 27, 2025, 4:00 PM
6.50
+0.04 (0.62%)
After-hours: Jun 27, 2025, 7:21 PM EDT
Bausch Health Companies Revenue
Bausch Health Companies had revenue of $2.26B in the quarter ending March 31, 2025, with 4.92% growth. This brings the company's revenue in the last twelve months to $9.73B, up 8.53% year-over-year. In the year 2024, Bausch Health Companies had annual revenue of $9.63B with 9.91% growth.
Revenue (ttm)
$9.73B
Revenue Growth
+8.53%
P/S Ratio
0.24
Revenue / Employee
$470,097
Employees
20,700
Market Cap
2.39B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 9.63B | 868.00M | 9.91% |
Dec 31, 2023 | 8.76B | 633.00M | 7.79% |
Dec 31, 2022 | 8.12B | -310.00M | -3.68% |
Dec 31, 2021 | 8.43B | 407.00M | 5.07% |
Dec 31, 2020 | 8.03B | -574.00M | -6.67% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
BHC News
- 2 days ago - Bausch + Lomb Announces Closing of Upsized €675 Million Senior Secured Notes Offering and Partial Credit Agreement Refinancing, Including Upsized $2.325 Billion Term Loan Facility - Business Wire
- 6 days ago - A Billionaire Trump Supporter Is Buying These Two Stocks - Barrons
- 10 days ago - Bausch Health Shares Rise as Nonexecutive Chairperson Paulson Buys $21.2M in Shares - Market Watch
- 12 days ago - Repricing Potential Driven By Deleveraging - Seeking Alpha
- 24 days ago - Bausch + Lomb Launches Blink® Nourish Lubricating Eye Drops and Blink Boost Lubricating Eye Drops in the United States - Business Wire
- 5 weeks ago - Facial Injectable Market Forecasts Report 2025-2030, Competitive Analysis of Key Players - Allergan, Bausch Health, Bloomage Biotechnology, and Galderma - GlobeNewsWire
- 5 weeks ago - Bausch + Lomb Launches New LUMIFY® Preservative Free Redness Reliever Eye Drops in the United States - Business Wire
- 6 weeks ago - Bausch Health Announces 2025 Annual Meeting of Shareholder Results - Accesswire